KK
Keith Kanik
Rheumatology
Credentials: · · ·
Research
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
New England Journal of Medicine · 2022 · 1,444 citations
Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis
New England Journal of Medicine · 2012 · 809 citations
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
New England Journal of Medicine · 2017 · Last of 12 authors · 428 citations
- RW
8 papers
- FV
7 papers
- RF
7 papers
- JK
6 papers
5 papers
- JC
5 papers · 5 as a fellow
- PM
5 papers
- AD
4 papers